Akums Drugs & Pharmaceuticals Board Meeting to Approve Quarterly Results
Akums Drugs & Pharmaceuticals will hold a board meeting on February 13, 2026, to consider and approve the unaudited standalone and…
Advanced Enzymes Q3 FY26 Earnings Rise 2% YoY, 9M Revenue Up 15%
Advanced Enzymes reported a 2% year-over-year increase in revenue for Q3 FY26, reaching ₹1,719 million. Despite a 7% sequential decline,…
Bharat Dynamics Interim Dividend Declared at ₹4.50 Per Share
Bharat Dynamics Limited (BDL) has announced an interim dividend of ₹4.50 per share for the financial year 2025-26. The decision was made…
Bharat Dynamics Interim Dividend Declared; Board Approves Financial Results
Bharat Dynamics Limited’s board has approved the unaudited financial results for the quarter and nine months ended December 31, 2025. An…
Advanced Enzymes Lawsuit Reversed, ₹159.64 Million Provision Reversed
Advanced Enzymes Technologies Ltd. has announced a favorable resolution in its lawsuit against World Nutrition Inc. The decision of the United…
Birla Corporation Board Approves Extension of Key Executives’ Terms
Birla Corporation’s Board of Directors has approved the extension of terms for two key senior management personnel. Shri Kalidas…
Bharat Dynamics Board Declares Interim Dividend of ₹4.50 Per Share
The Board of Directors of Bharat Dynamics Limited has declared an interim dividend of ₹4.50 per share, for the financial year 2025-26. This…
Clean Science Board Approves Q3 FY26 Results, Declares ₹2 Interim Dividend
Clean Science and Technology Limited’s board has approved the unaudited standalone and consolidated financial results for Q3 FY26,…
Birla Corporation Board Approves Extension of Senior Management Terms
The Board of Directors of Birla Corporation has approved the extension of terms for two senior management personnel. Shri Kalidas…
Clean Science Board Approves Q3 Results, Declares ₹2 Interim Dividend
Clean Science and Technology Limited’s board approved the unaudited standalone and consolidated financial results for Q3 FY26…